RESEARCH PAPER
Precision public health – hopes and threats
 
 
More details
Hide details
1
Department of Epidemiology and Biostatistics, Institute of Rural Health, Lublin, Poland
 
 
Corresponding author
Maria Nowacka   

Department of Epidemiology and Biostatistics, Institute of Rural Health, Lublin, Poland
 
 
 
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
The article formulates the following theses and conclusion: (1) the development processes of precision medicine and precision public health (PPH) are correlated; (2) the development of public health genomics depends not only on an increasingly complete exploration of the principles of the human genome, but also on a fundamentally better investigation of how broad environmental factors can alter gene expression or structure; (3) a necessary condition for the development of both precision medicine and precision public health is the collection of increasingly broader and more complete information about pro- and anti-health factors; (4) the above necessary condition is only possible in a situation of strong authoritarianism with regard to taking health-promoting measures. It is likely that in the near future public health will be shaped by health-promoting authoritarianism.

Brief description of the state of knowledge:
There are two main problems in the development of precise public health (PPH). The first, is maintaining the right proportions between actions based on the genomic data, and actions determined by better understanding of the effect of environmental factors. The second, is the necessity to subject individuals and populations to increasingly closer pro-health surveillance, which must be increasingly more effective, forcing specific health-promoting behaviours on individual and social scales.

Summary:
PPH in full can only exist in conditions of complete information concerning health determinants of an individual, and each distinguished group of individuals, as well as fully pro-health organization of individual and social life, i.e. in conditions of full individual and social medicalization. However, such a full medicalization cannot be achieved in any way other than authoritarian.

 
REFERENCES (28)
1.
Molster CM, et al. The Evolution of Public Health Genomics. Exploring its Past, Present, and Future. „Frontiers in Public Health/www.frontiersin.org” 6, 247, 2018 [access: 17.05.2023].
 
2.
Khoury M J. Dr. Muin J. Khoury Discusses the Future of Public Health Genomics and why it Matters for Personalized Medicine and Global Health. Curr Pharmacog Personalized Med. 2009;7:158–163.
 
3.
Burke W, et al. The Path from Genome-Based Research to Population Health: Development of an International Public Health Genomics Network. Genetics Med. 2006;8(7):451–458.
 
4.
Khoury MJ, et al. From public health genomics to precision public health: a 20-year journey. Gen Med. 2018; 20(6):574–582.
 
5.
Weeramanthri TS, et al. Precision Public Health. Frontiers in Public Health/www.frontiersin.org 2017; 6: 121 [access: 17.05.2023].
 
6.
Dowell SF, Blazes D, Desmond-Hellmann S. Four Steps to Precision Public Health. Nature 2016;540:189–191.
 
7.
Rubin R. Precision Medicine: The Future or Simply Politics? J Am Medical Assoc. 2015;313(11):1089–1091.
 
8.
Khoury MJ, Iademarco MF, Riley WT. Precision Public Health for the Era of Precision Medicine. Am J Prev Med. 2016;50(3):398–401.
 
9.
Genomics and Population Health: United States 2003, Centers for Disease Control and Prevention, Office of Genomics and Disease Prevention, Atlanta, GA, 2004: p. 94; http://www.cdc.gov/genomics [access: 31.05.2023].
 
10.
Omenn GS. Genomics and Public Health. Iss Sci Technol. 2005;21(3):42–48.
 
11.
Evans JP, et al. We Screen Newborns, don’t we? Realizing the Promise of Public Health Genomics. Gen Med. 2013;15(5):332–334.
 
12.
Evans J. A Promising – and Practical – Vision for Public Health Genomics. GeneWatch. 2015;28(1):1–2.
 
13.
Merikangas KR, Risch N. Genomics Priorities and Public Health. Sci. 2003;24:599–601.
 
14.
Burguete A, Bermúdez-Morales VH, Madrid-Marina V. Medicina genómica aplicada a la salud pública. Salud Pública de México. 2009;51:379–385.
 
15.
Brand A, Brand H, Schulte T. The Impact of Genetics and Genomics on Public Health. Eur J Human Gen. 2008;16:5–13.
 
16.
Brand A, Dabrock PN, Schröder P. Gesundheitssicherung im Zeitalter der Genomforschung – Diskussion, Aktivita¨ten und Institutionalisierung von Public Health Genetics in Deutschland. Gutachten zur Bio- und Gentechnologie, Friedrich-Ebert-Stiftung, Berlin 2004.
 
17.
Hall WD, Mathews R, Morley KI. Being more Realistic about the Public Health Impact of Genomic Medicine. PLoS Med. 2010;7:1–4; www.plosmedicine.org [access: 31.05.2023].
 
18.
Rosso A, et al. Genomics Knowledge and Attitudes among European Public Health Professionals: Results of a Cross-sectional Survey. PLoS One. 2020;15:4. https://pubmed.ncbi.nlm.nih.go... [access: 31.05.2023].
 
19.
Niemchick KL, et al. Are We Prepared for Precision Public Health? An Examination of Genomics Content in Graduate Public Health Programs. Public Health Rep. 2022;137:1242–1247.
 
20.
Propp T, Moors EHM. Will Genomics Erode Public Health and Prevention? A Scenario of Unintended Consequences in the Netherlands. Sci Public Policy 2009;36:199–213.
 
21.
Wu JB, Comfort NC. Precision Medicine for the Population – The Hope and Hype of Public Health Genomics. Chance. 2023;36:25–27.
 
22.
Galasso I. Precision Medicine for Whom? Public Health Outputs from ‘Genomics England’ and ‘All of Us’ to Make Up for Upstream and Downstream Exclusion. Am J Bioethics. 2023;6:1–15. www.frontiersin.org” 6, 121, 2017 [access: 17.05.2023].
 
23.
Wilkinson J. Public Health Observatories in England. Recent Transformations and Continuing the Legacy. Cadernos de Saúde Pública. 2015;31(suppl. 1):269–276.
 
24.
Wilkinson J R, et al. Public Health Genomics. The Interface with Public Health Intelligence and the Role of Public Health Observatories. Public Health Gen. 2011;14(1):35–42.
 
25.
Khoury MJ, Engelgau M, Chambers A, Mensah GA. Beyond Public Health Genomics. Can Big Data and Predictive Analytics Deliver Precision Public Health? Public Health Gen. 2018;21:244–250.
 
26.
Khoury MJ, et al. The Intersection of Genomics and Big Data with Public Health. Opportunities for Precision Public Health. PLoS Med. 2020:1–14.
 
27.
Arnett DK, Class SA. Precision Medicine, Genomics, and Public Health. Diabetes Care 2016; 39: 11 https://diabetesjournals.org/c... Health [access: 27.07.2023].
 
28.
Roberts MC, et al. Advancing Precision Public Health Using Human Genomics. Examples from the Field and Future Research Opportunities. Genome Med. 2021;13:1–10.
 
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Scroll to top